FPRX

Five Prime Therapeutics, Inc. Press Releases

$14.92
*  
0.28
 negative 
1.91%
Get FPRX Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Five Prime Therapeutics Announces Upcoming Presentations at the 2014 American Association for Cancer Research Meeting
3/27/2014 7:27:00 PM - GlobeNewswire

Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results
3/25/2014 4:05:00 PM - GlobeNewswire

Earnings Release and Presentation Schedules, Nominations, and Financial Results - Analyst Notes on Five Prime Therapeutics, Acceleron, Emergent BioSolutions, CONMED, and ImmunoGen
3/21/2014 8:00:00 AM - PR Newswire

Five Prime Therapeutics to Present at Future Leaders in the Biotech Industry
3/20/2014 4:05:00 PM - GlobeNewswire

Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2013 Financial Results and Host Conference Call on March 25
3/18/2014 9:00:00 AM - GlobeNewswire

Immune Design Appoints Franklin M. Berger to Board of Directors
3/18/2014 8:00:00 AM - PR Newswire

Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways
3/17/2014 6:59:00 AM - Business Wire

Five Prime Therapeutics to Present at 26th Annual Roth Conference
3/5/2014 4:15:00 PM - GlobeNewswire

Five Prime Therapeutics Announces Closing of Public Offering
2/12/2014 4:05:00 PM - GlobeNewswire

Five Prime Announces the Full Exercise of the Underwriters' Option to Purchase Additional Shares
2/10/2014 9:15:00 AM - GlobeNewswire

Five Prime Therapeutics Prices Public Offering of Common Stock
2/6/2014 11:18:00 PM - GlobeNewswire

Five Prime Therapeutics to Present at BIO CEO
2/3/2014 4:05:00 PM - GlobeNewswire